92 results
Page 5 of 5
6-K
EX-99.1
khrb1shq3rdnax947n
12 Dec 18
Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA
7:35am
6-K
EX-99.1
ytgsdaijw4a
30 Nov 18
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development
6:06am
6-K
2cd5 vlacvwcof
30 Nov 18
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development
6:06am
6-K
EX-99.1
5y3lrh02r 0hg6
22 Oct 18
Zai Lab Announces Approval of ZEJULA® (Niraparib) for Patients with Relapsed Ovarian Cancer in Hong Kong
7:48am
424B4
oj5lkco9zyhk7o5c
7 Sep 18
Prospectus supplement with pricing info
12:00am
6-K
EX-99.1
gckv7ksgyfcho1tbcdhm
14 Aug 18
Zai Lab Appoints Professor Kai-Xian Chen, Ph.D., to its Board of Directors
7:36am
6-K
EX-99.1
78ci1pbj ilf
5 Jun 18
Zai Lab Expands Commercial Leadership Team, Appoints William Liang as Chief Commercial Officer
12:00am
6-K
EX-99.1
67r60 xmc
2 May 18
Zai Lab Reports Full Year 2017 Financial Results and Corporate Update
7:14am
20-F
EX-4.11
rewn5fhd8
30 Apr 18
Annual report (foreign)
9:07am
20-F
yjog88bwj
30 Apr 18
Annual report (foreign)
9:07am